Screener
ADMA Biologics ADMA Long-Term Debt
Long-Term Debt at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.
The source filing: ADMA Biologics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:16 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001140361-26-031445
FAQ
- What is ADMA Biologics's long-term debt?
- ADMA Biologics (ADMA) reported long-term debt of $192.84M in Q2 2026.
- What is the long-term trend for ADMA Biologics's long-term debt?
- Over 2 years (2020 to 2025), ADMA Biologics's long-term debt has grown at a -13.6% compound annual growth rate (CAGR), from $92.97M to $69.33M.
- What does long-term debt mean?
- Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.
Ask your AI about ADMA Biologics's long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude